CADI-T1032

CADI-T1032 is a therapeutic program developed by Bio-Modeling Systems (BMSystems) using its proprietary CADI™ (Computer-Aided Drug Identification) systems biology platform. The program is designed to address complex challenges in the fields of infection and immunology, with a primary focus on host-pathogen interactions. Specifically, CADI-T1032 has been utilized to model the immune response to infectious agents, such as *Mycobacterium tuberculosis*, to identify novel therapeutic protocols. These protocols aim to modulate the host's immune system to enhance the clearance of pathogens and overcome issues like multi-drug resistance. As a CADI-derived program, it represents a mechanistic discovery phase that identifies specific biological targets and existing drugs or combinations for repurposing to achieve desired immunological outcomes.